𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Volumetric and shape analysis of the thalamus in first-episode schizophrenia

✍ Scribed by Denise M. Coscia; Katherine L. Narr; Delbert G. Robinson; Liberty S. Hamilton; Serge Sevy; Katherine E. Burdick; Handan Gunduz-Bruce; Joanne McCormack; Robert M. Bilder; Philip R. Szeszko


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
255 KB
Volume
30
Category
Article
ISSN
1065-9471

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Thalamic abnormalities have been implicated in the pathogenesis of schizophrenia, although the majority of studies used chronic samples treated extensively with antipsychotics. Moreover, the clinical and neuropsychological correlates of these abnormalities remain largely unknown. Using high‐resolution MR imaging and novel methods for shape analysis, we investigated thalamic subregions in 35 (25 M/10 F) first‐episode schizophrenia patients compared with 33 (23 M/10 F) healthy volunteers. The right and left thalami were traced bilaterally on coronal brain slices and volumes were compared between groups. In addition, regional abnormalities were identified by comparing distances, measured from homologous thalamic surface points to the central core of each individual's surface model, between groups in 3D space. Patients had significantly less total thalamic volume compared with healthy volunteers. Statistical mapping demonstrated most pronounced shape abnormalities in the pulvinar; however, estimated false discovery rates in these regions were sizable. Smaller thalamus volume was significantly correlated with worse overall neuropsychological functioning and specific deficits were observed in the language, motor, and executive domains. There were no significant associations between thalamus volume and positive or negative symptoms. Our findings suggest that thalamic abnormalities are evident at the onset of a first episode of schizophrenia prior to extensive pharmacologic intervention and that these abnormalities have neuropsychological correlates. Hum Brain Mapp, 2009. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Surface-based morphometry of the anterio
✍ Alex Fornito; Murat Yücel; Stephen J. Wood; Chris Adamson; Dennis Velakoulis; Mi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

## Abstract The anterior cingulate cortex (ACC) appears to be critically involved in the pathophysiology of schizophrenia, but past attempts at characterizing pathological changes in the region using magnetic resonance imaging have been restricted by a limited appreciation of its functional and ana

Effect of blonanserin on cognitive funct
✍ Tomomi Tenjin; Seiya Miyamoto; Nobumi Miyake; Shin Ogino; Rei Kitajima; Kazuaki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Objective The purpose of this study was to evaluate the effects of blonanserin, a novel antipsychotic, on cognitive function in first‐episode schizophrenia. ## Methods Twenty‐four antipsychotic‐naïve patients with first‐episode schizophrenia participated in the study. Blonanserin was given in

Source-based morphometry of gray matter
✍ Tomáš Kašpárek; Radek Mareček; Daniel Schwarz; Radovan Přikryl; Jiří Vaníček; Mi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 1 views

## Abstract Objectives: There is a lot of variability between the results of studies reporting the pattern of gray matter volume changes in schizophrenia. Methodological issues may play an important role in this heterogeneity. The aim of the present study was to replicate the better performance of

Aripiprazole altered plasma levels of br
✍ Reiji Yoshimura; Hikaru Hori; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Asuk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 1 views

## Objective We investigated the effects of aripiprazole on plasma levels of brain‐derived neurotrophic factor (BDNF) and catecholamine metabolites in first‐episode untreated schizophrenia patients. ## Methods The subjects were 50 Japanese first‐episode untreated schizophrenia patients who met th

Remoxipride versus thioridazine in the t
✍ T. Lambert; N. Keks; J. McGrath; S. Catts; H. Hustig; K. Vaddadi; G. Burrows; F. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB

Remoxipride, a substituted benzamide, is a selective D2 antagonist with an atypical neuroleptic profile. Previous studies have demonstrated its antipsychotic efficacy against haloperidol and, more recently, thioridazine. Of the 144 patients enrolled in the Australian remoxipride-thioridazine compara